Particularly TRAIL resistant tumors, but also sensitive tumor cells can respond by expressing or secreting factors that inhibit immune effector cell-induced apoptosis or even eradicate immune cells by TRAIL/TRAIL-R dependent mechanisms. This evidence concerns the gene TNFSF10 and neoplasm.